Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Tract Therapeutics
AddedFeb 15, 2024
UpdatedJun 18, 2026
Tract Therapeutics

Tract Therapeutics

Series B

Nova Biomedical: Innovating immune balance restoration for solid organ transplant patients.

HQ
Chicago, IL, US
Founded
2013
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to restore immune balance in patients receiving solid organ transplants, TRACT Therapeutics is pioneering personalized medical solutions. The company’s core product, TregCel™, utilizes a patient's own regulatory T cells, expanded in a lab and re-infused to establish immune tolerance. This innovative approach aims to improve outcomes for transplant patients and those suffering from autoimmune disorders, focusing on personalized and effective treatments.

TRACT Therapeutics has attracted attention from notable investors and experts in the biotech industry. The company’s advancements have been recognized for their potential to significantly impact transplant medicine and autoimmune disease management. By leveraging cutting-edge science and technology, TRACT Therapeutics is poised to make substantial contributions to patient care and the broader medical community.

Tract Therapeutics - Similar Companies

Tr1x logo

Tr1x

tr1x.bio

Sonoma Biotherapeutics logo

Sonoma Biotherapeutics

Tactiva Therapeutics logo

Tactiva Therapeutics

TregTherapeutics logo

TregTherapeutics

Abata Therapeutics logo

Abata Therapeutics

abatatx.com

TRex Bio logo

TRex Bio

trex.bio

GentiBio logo

GentiBio

gentibio.com

Tmunity Therapeutics logo

Tmunity Therapeutics

Janux Therapeutics logo

Janux Therapeutics

januxrx.com

Medeor Therapeutics logo

Medeor Therapeutics

medeortx.com

Trefoil Therapeutics logo

Trefoil Therapeutics

Endogena Therapeutics logo

Endogena Therapeutics

Celularity logo

Celularity

celularity.com

Akttyva Therapeutics logo

Akttyva Therapeutics

akttyva.com

Modulus Therapeutics logo

Modulus Therapeutics

Tract Therapeutics - Quick Facts

Who are Tract Therapeutics' competitors?

Companies similar to Tract Therapeutics include Tr1x, Sonoma Biotherapeutics, Tactiva Therapeutics and TregTherapeutics.

When was Tract Therapeutics founded?

Tract Therapeutics was founded in 2013.

Where is Tract Therapeutics' headquarters located?

Tract Therapeutics' headquarters is located in Chicago, IL, US.

When was Tract Therapeutics' last funding round?

Tract Therapeutics' most recent funding round was for $15M (USD) in March 2019.

How much has Tract Therapeutics raised to-date?

As of Mar 18, 2019, Tract Therapeutics has raised a total of $15M (USD).

How many employees does Tract Therapeutics have?

Tract Therapeutics has 5 employees as of Feb 5, 2024.

Tract Therapeutics - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Medical
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified